SI-BONE (NASDAQ:SIBN) Announces Earnings Results, Beats Estimates By $0.05 EPS

SI-BONE (NASDAQ:SIBN) released its quarterly earnings results on Monday. The company reported ($0.11) EPS for the quarter, beating analysts’ consensus estimates of ($0.16) by $0.05, Zacks reports. SI-BONE had a negative return on equity of 22.51% and a negative net margin of 23.82%. SI-BONE updated its FY 2025 guidance to EPS.

SI-BONE Stock Down 2.1 %

Shares of SIBN stock traded down $0.37 during mid-day trading on Monday, reaching $17.47. 481,703 shares of the company’s stock traded hands, compared to its average volume of 337,872. The company has a quick ratio of 7.22, a current ratio of 8.25 and a debt-to-equity ratio of 0.22. The company’s 50-day moving average price is $15.65 and its 200-day moving average price is $14.66. The company has a market cap of $732.66 million, a P/E ratio of -18.99 and a beta of 1.17. SI-BONE has a 12 month low of $11.70 and a 12 month high of $20.60.

Analysts Set New Price Targets

A number of analysts recently commented on the company. Needham & Company LLC reaffirmed a “buy” rating and issued a $19.00 price target on shares of SI-BONE in a research note on Monday, January 13th. Truist Financial raised their target price on shares of SI-BONE from $16.00 to $18.00 and gave the stock a “buy” rating in a research report on Wednesday, November 13th. Six investment analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the company currently has an average rating of “Buy” and an average price target of $23.00.

Insider Activity at SI-BONE

In other SI-BONE news, CFO Anshul Maheshwari sold 5,304 shares of SI-BONE stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $13.91, for a total transaction of $73,778.64. Following the completion of the transaction, the chief financial officer now owns 189,319 shares in the company, valued at approximately $2,633,427.29. The trade was a 2.73 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Anthony J. Recupero sold 3,670 shares of the stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $13.90, for a total value of $51,013.00. Following the completion of the sale, the insider now directly owns 222,814 shares in the company, valued at approximately $3,097,114.60. This represents a 1.62 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 9,311 shares of company stock valued at $130,356 in the last three months. Company insiders own 3.90% of the company’s stock.

SI-BONE Company Profile

SI-BONE, Inc, a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products.